Satoru Senju

7.2k citations

101 papers · 5.8k indexed · 1 hit paper · h-index 38

Immunology top 0.5%
- Immunotherapy and Immune Responses 52
- Immune Cell Function and Interaction 32
- T-cell and B-cell Immunology 21
- Immune cells in cancer 9
Oncology top 1%
- CAR-T cell therapy research 30
- Cancer Immunotherapy and Biomarkers 9
Molecular Biology top 2%
- RNA Interference and Gene Delivery 15
- vaccines and immunoinformatics approaches 8
Hepatology top 5%
Cancer Research top 5%

Co-authors: Yasuharu Nishimura Noboru Motoyama Keiko Nakayama Dennis Y. Loh Izumi Negishi Kei-ichi Nakayama Tetsuya Nakatsura Tokunori Ikeda
Cited by: Immunology Oncology Molecular Biology
Journals: Nature (1 paper)Science (2 papers)Journal of Biological Chemistry (1 paper)
Partner nations: Japan United States Germany

In The Last Decade

Satoru Senju

101 papers receiving 5.7k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Satoru Senju

Since Specialization

Citations

This map shows the geographic impact of Satoru Senju's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoru Senju with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoru Senju more than expected).

Fields of papers citing papers by Satoru Senju

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satoru Senju. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoru Senju. The network helps show where Satoru Senju may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Satoru Senju, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Satoru Senju Line = papers co-authored together Satoru Senju links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Immune cell therapy against disseminated melanoma by utilizing induced pluripotent stem cell-derived myeloid cell lines producing interferon-beta or interleukin-15/interleukin-15 receptor alpha Journal of Dermatological Science ·Satoru Mizuhashi,Yosuke Kubo,Satoshi Fukushima,Hisashi Kanemaru,Satoshi Nakahara,Azusa Miyasita,Takayuki Ishibashi,Haruka Kuriyama,Toshihiro Kimura,Shinichi Masuguchi,Rong Zhang,Tatsuaki Iwama,Tetsuya Nakatsura,Yasushi Uemura,Satoru Senju,Hironobu Ihn	2021	1
2	Combined Blockade of IL6 and PD-1/PD-L1 Signaling Abrogates Mutual Regulation of Their Immunosuppressive Effects in the Tumor Microenvironment Cancer Research ·Hirotake Tsukamoto,Koji Fujieda,Azusa Miyashita,Satoshi Fukushima,Tokunori Ikeda,Yosuke Kubo,Satoru Senju,Hironobu Ihn,Yasuharu Nishimura,Hiroyuki Oshiumi	2018	234
3	Soluble IL6R Expressed by Myeloid Cells Reduces Tumor-Specific Th1 Differentiation and Drives Tumor Progression Cancer Research ·Hirotake Tsukamoto,Koji Fujieda,Masatoshi Hirayama,Tokunori Ikeda,Akira Yuno,Keiko Matsumura,Daiki Fukuma,Kimi Araki,Hiroshi Mizuta,Hideki Nakayama,Satoru Senju,Yasuharu Nishimura	2017	46
4	Immunotherapy against Metastatic Melanoma with Human iPS Cell–Derived Myeloid Cell Lines Producing Type I Interferons Cancer Immunology Research ·Azusa Miyashita,Satoshi Fukushima,Satoshi Nakahara,Yosuke Kubo,Aki Tokuzumi,Junji Yamashita,Jun Aoi,Miwa Haruta,Satoru Senju,Yasuharu Nishimura,Masatoshi Jinnin,Hironobu Ihn	2016	24
5	Ribosome stalling induced by mutation of a CNS-specific tRNA causes neurodegeneration Science ·Ryuta Ishimura,Gábor Nagy,Iván Dotú,Huihao Zhou,Xiang‐Lei Yang,Paul Schimmel,Satoru Senju,Yasuharu Nishimura,Jeffrey H. Chuang,Susan L. Ackerman	2014	328
6	Suppression of Th1-Mediated Autoimmunity by Embryonic Stem Cell-Derived Dendritic Cells PLoS ONE ·Tokunori Ikeda,Shinya Hirata,Koutaro Takamatsu,Miwa Haruta,Hirotake Tsukamoto,Takaaki Ito,Makoto Uchino,Yukio Ando,Seiho Nagafuchi,Yasuharu Nishimura,Satoru Senju	2014	11
7	Therapy of Peritoneally Disseminated Colon Cancer by TAP-Deficient Embryonic Stem Cell–Derived Macrophages in Allogeneic Recipients The Journal of Immunology ·Eriko Haga,Yuko Endo,Miwa Haruta,Chihiro Koba,Keiko Matsumura,Koutaro Takamatsu,Tokunori Ikeda,Yasuharu Nishimura,Satoru Senju	2014	11
8	Application of iPS cell-derived macrophages to cancer therapy OncoImmunology ·Satoru Senju,Chihiro Koba,Miwa Haruta,Yusuke Matsunaga,Keiko Matsumura,Eriko Haga,Yuko Sasaki,Tokunori Ikeda,Koutaro Takamatsu,Yasuharu Nishimura	2014	12
9	Identification of Promiscuous KIF20A Long Peptides Bearing Both CD4+ and CD8+ T-cell Epitopes: KIF20A-Specific CD4+ T-cell Immunity in Patients with Malignant Tumor Clinical Cancer Research ·Yusuke Tomita,Akira Yuno,Hirotake Tsukamoto,Satoru Senju,Yasuhiro Kuroda,Masatoshi Hirayama,Atsushi Irie,Kenta Kawahara,Junji Yatsuda,Akinobu Hamada,Hirofumi Jono,Koji Yoshida,Takuya Tsunoda,Hirotsugu Kohrogi,Yoshihiro Yoshitake,Yusuke Nakamura,Masanori Shinohara,Yasuharu Nishimura	2013	50
10	Myeloid-Derived Suppressor Cells Attenuate TH1 Development through IL-6 Production to Promote Tumor Progression Cancer Immunology Research ·Hirotake Tsukamoto,Ryutaro Nishikata,Satoru Senju,Yasuharu Nishimura	2013	69
11	Therapeutic Effect of Human iPS-Cell–Derived Myeloid Cells Expressing IFN-β against Peritoneally Disseminated Cancer in Xenograft Models PLoS ONE ·Chihiro Koba,Miwa Haruta,Yusuke Matsunaga,Keiko Matsumura,Eriko Haga,Yuko Sasaki,Tokunori Ikeda,Koutaro Takamatsu,Yasuharu Nishimura,Satoru Senju	2013	41
12	Identification of a Novel Tumor-Associated Antigen, Cadherin 3/P-Cadherin, as a Possible Target for Immunotherapy of Pancreatic, Gastric, and Colorectal Cancers Clinical Cancer Research ·Katsunori Imai,Shinya Hirata,Atsushi Irie,Satoru Senju,Yoshiaki Ikuta,Kazunori Yokomine,Michiko Harao,Mitsuhiro Inoue,Takuya Tsunoda,Shuichi Nakatsuru,Hidewaki Nakagawa,Yusuke Nakamura,Hideo Baba,Yasuharu Nishimura	2008	90
13	Identification of the H2‐K^d‐restricted cytotoxic T lymphocyte epitopes of a tumor‐associated antigen, SPARC, which can stimulate antitumor immunity without causing autoimmune disease in mice Cancer Science ·Yoshiaki Ikuta,Yuki Hayashida,Shinya Hirata,Atsushi Irie,Satoru Senju,Tatsuko Kubo,Tetsuya Nakatsura,Mikio Monji,Yutaka Sasaki,Hideo Baba,Yasuharu Nishimura	2008	7
14	Involvement of Regulatory T Cells in the Experimental Autoimmune Encephalomyelitis-Preventive Effect of Dendritic Cells Expressing Myelin Oligodendrocyte Glycoprotein plus TRAIL The Journal of Immunology ·Shinya Hirata,Hidetake Matsuyoshi,Daiki Fukuma,Akari Kurisaki,Yasushi Uemura,Yasuharu Nishimura,Satoru Senju	2007	42
15	Regression of intestinal adenomas by vaccination with heat shock protein 105‐pulsed bone marrow‐derived dendritic cells in Apc^Min/+ mice Cancer Science ·Kazunori Yokomine,Tetsuya Nakatsura,Satoru Senju,Naomi Nakagata,Motozumi Minohara,Jun‐ichi Kira,Yutaka Motomura,Tatsuko Kubo,Yutaka Sasaki,Yasuharu Nishimura	2007	15
16	Prevention of Experimental Autoimmune Encephalomyelitis by Transfer of Embryonic Stem Cell-Derived Dendritic Cells Expressing Myelin Oligodendrocyte Glycoprotein Peptide along with TRAIL or Programmed Death-1 Ligand The Journal of Immunology ·Shinya Hirata,Satoru Senju,Hidetake Matsuyoshi,Daiki Fukuma,Yasushi Uemura,Yasuharu Nishimura	2005	109
17	DNA vaccination of HSP105 leads to tumor rejection of colorectal cancer and melanoma in mice through activation of both CD4⁺ T cells and CD8⁺ T cells Cancer Science ·Masafumi Miyazaki,Tetsuya Nakatsura,Kazunori Yokomine,Satoru Senju,Mikio Monji,Seiji Hosaka,Hiroyuki Komori,Yoshihiro Yoshitake,Yutaka Motomura,Motozumi Minohara,Tatsuko Kubo,Keiichi Ishihara,Takumi Hatayama,Michio Ogawa,Yasuharu Nishimura	2005	26
18	Enhanced Priming of Antigen-Specific CTLs In Vivo by Embryonic Stem Cell-Derived Dendritic Cells Expressing Chemokine Along with Antigenic Protein: Application to Antitumor Vaccination The Journal of Immunology ·Hidetake Matsuyoshi,Satoru Senju,Shinya Hirata,Yoshihiro Yoshitake,Yasushi Uemura,Yasuharu Nishimura	2004	55
19	Immunocytochemical Analyses and Targeted Gene Disruption of GTPBP1 Molecular and Cellular Biology ·Satoru Senju,Ken‐ichi Iyama,Hironori Kudo,Shinichi Aizawa,Yasuharu Nishimura	2000	25
20	Massive Cell Death of Immature Hematopoietic Cells and Neurons in Bcl-x-Deficient Micebreakdown → Science ·Noboru Motoyama,Fanping Wang,Kevin A. Roth,Hirofumi Sawa,Kei-ichi Nakayama,Keiko Nakayama,Izumi Negishi,Satoru Senju,Qing Zhang,Satoshi Fujii,Dennis Y. Loh	1995	969

About Satoru Senju

Satoru Senju is a scholar working on Immunology, Oncology and Biotechnology, having authored 101 papers that have together received 5.8k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (52 papers), Immune Cell Function and Interaction (32 papers), CAR-T cell therapy research (30 papers), T-cell and B-cell Immunology (21 papers), RNA Interference and Gene Delivery (15 papers), Cancer Immunotherapy and Biomarkers (9 papers), Immune cells in cancer (9 papers) and vaccines and immunoinformatics approaches (8 papers). The work is most often cited by research in Immunology (2.7k citations), Oncology (1.8k citations) and Molecular Biology (3.1k citations). Satoru Senju has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Yasuharu Nishimura, Noboru Motoyama, Keiko Nakayama, Dennis Y. Loh, Izumi Negishi, Kei-ichi Nakayama, Tetsuya Nakatsura, Tokunori Ikeda, Hirotake Tsukamoto and Shinya Hirata. Their work appears in journals such as Nature, Science and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact